Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial - Schoenfeld, J D; Hanna, G J; Jo, V Y (JAMA Oncol, 2020)